Results 31 to 40 of about 31,107,750 (262)

Markers of hepatitis A in the monkeys of the Adlers primate center

open access: yesВопросы вирусологии, 2019
Hepatitis A is a widespread viral infection. The HAV strains of “human” and “monkey” origin are similar in their morphological and antigenic properties, but differ genotypically.
D. I. Dogadov   +5 more
doaj   +1 more source

Hepatitis E update [PDF]

open access: yesHepatology Forum, 2020
Hepatitis E virus (HEV) infection is estimated to be one of the commonest causes of acute hepatitis in the world. All patients with symptoms consistent with acute hepatitis should be tested for HEV. HEV was thought to be limited to certain developing countries until the last decade and was only ever seen in travellers of developed countries in ...
openaire   +2 more sources

Seroprevalence and risk factors for hepatitis E virus infection in the Romanian adult population: a cross-sectional study in a tertiary hospital

open access: yesRomanian Journal of Laboratory Medicine, 2019
Background: The primary goal was to estimate the seroprevalence of autochthonous hepatitis E virus (HEV) infection in adult Romanian population. Additionally, we aimed to identify the risk factors associated with the HEV seropositive status.
Gheorghiță Valeriu   +6 more
doaj   +1 more source

The Genetic Analysis of Potential New HEV-3 Subtype Identified on Pig Farm in Slovakia

open access: yesFolia Veterinaria, 2023
Hepatitis E virus (HEV) represents the causative agent of acute viral hepatitis in the world. The virus belongs to the genus Paslahepevirus, species Paslahepevirus balayani, which contains 8 different genotypes and at least 14 reference HEV-3 subtypes ...
Kočíková Božena   +4 more
doaj   +1 more source

Development of new hepatitis E vaccines

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Hepatitis E virus (HEV) infection is an emerging zoonotic disease posing a severe threat to public health in the world, especially to pregnant women. Currently, no specific treatments are available for HEV infection.
Yufeng Cao   +4 more
doaj   +1 more source

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

open access: yes, 1999
Hepatitis C is a global health problem caused by infection with the hepatitis C virus. Although representative prevalence data are not available from many countries, available data indicate that approximately 3% of the world's population is infected with
A.R. ZANETTI   +1 more
core   +1 more source

An acute infection due to hepatitis E in the context of a patient with rituximab and methotrexate therapy

open access: yesEuropean Journal of Case Reports in Internal Medicine
Background: This report presents the influence of immunosuppression by new rheumatological therapies on hepatitis E virus infection in a 54-year-old male patient with an anti-synthetase syndrome and treatment with methotrexate and rituximab.
Francisco Josué Cordero Pérez   +6 more
doaj   +1 more source

A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection

open access: yesMedical Sciences, 2020
Hepatitis E virus (HEV) is a non-enveloped, positive-sense, single-stranded RNA icosahedral virus belongs to the genus Orthohepevirus within the Hepeviridae family. HEV infection can be asymptomatic, or it can cause icteric or fulminant hepatitis.
Prashanth Rawla   +5 more
doaj   +1 more source

Severe Hypercholesterolemia Mediated by Lipoprotein X in an Immunosuppressed Patient: A Case Report

open access: yesGE: Portuguese Journal of Gastroenterology, 2022
Cholestatic liver diseases may be associated with increased plasmatic cholesterol due to an abnormal lipoprotein – lipoprotein X (LpX). Correcting the underlying cause of cholestasis is the critical treatment of LpX-associated hypercholesterolemia ...
Cristiana Sequeira   +5 more
doaj   +1 more source

Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance.

open access: yes, 2004
We examined correlates of antinuclear antibody (ANA) positivity (ANA+) in individuals with chronic hepatitis C virus (HCV) infection and the effect of positivity on clinical outcome of HCV. Pretreatment sera from 645 patients from three centres in Sweden
Marshall, S   +22 more
core   +1 more source

Home - About - Disclaimer - Privacy